Johnson & Johnson's (NYSE: JNJ) Janssen-Cilag International NV announced today it has submitted a type II variation to the European ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE